A fellow schwab member (Iqra) posted this and I thought it might be helpful to the members here:
There have been a couple of mentions lately about generics vs. brand-name meds. The Feb. Harvard Mental Health letter included this explanation which is the clearest I've read: The FDA requires that generics must contain the same amt. of active ingredient, and deliver about the same amt. into the bloodstream-- from 20% less to 25% more than the brand name. The inactive ingredients are different, which may change the way the active ingredient is absorbed, delivered, and eliminated. In testing new generics, the volunteers are usually given relatively small doses, so in real patients taking higher doses the actual difference could be greater than that -20% to +25%. So you may not need to pay the extra $ for brand name or fight with your insurance company if the doctor is willing to work with you on raising or lowering the dose according to symptoms.
"Courage is not the lack of fear, it is acting in spite of it." "What lies behind you and what lies in front of you, pales in comparison to what lies inside of you." "Count your age by friends, not years. Count your life by smiles, not tears." ― John Lennon “Death is Inevitable. Living a life we can be proud of is something we can control.” - Claire Wineland